Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for ZEB1
Z-value: 1.62
Motif logo
Transcription factors associated with ZEB1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZEB1
|
ENSG00000148516.17 | zinc finger E-box binding homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZEB1 | hg19_v2_chr10_+_31610064_31610159 | -0.48 | 6.6e-03 | Click! |
Activity profile of ZEB1 motif
Sorted Z-values of ZEB1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51471362 | 9.30 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51471381 | 9.20 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51504411 | 7.47 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
| chr13_-_20806440 | 6.49 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
| chr4_-_57522470 | 4.72 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr11_-_65667997 | 4.19 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
| chr4_+_75311019 | 3.98 |
ENST00000502307.1
|
AREG
|
amphiregulin |
| chr4_+_75310851 | 3.84 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr14_+_75745477 | 3.78 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr1_+_183155373 | 3.77 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr4_+_75480629 | 3.73 |
ENST00000380846.3
|
AREGB
|
amphiregulin B |
| chr1_+_152956549 | 3.70 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
| chr19_+_54926621 | 3.63 |
ENST00000376530.3
ENST00000445095.1 ENST00000391739.3 ENST00000376531.3 |
TTYH1
|
tweety family member 1 |
| chr11_-_65667884 | 3.61 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
| chr19_-_51472222 | 3.60 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr14_-_75422280 | 3.54 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
| chr3_-_50336548 | 3.53 |
ENST00000450489.1
ENST00000513170.1 ENST00000450982.1 |
NAT6
HYAL3
|
N-acetyltransferase 6 (GCN5-related) hyaluronoglucosaminidase 3 |
| chr7_+_18535786 | 3.52 |
ENST00000406072.1
|
HDAC9
|
histone deacetylase 9 |
| chr19_+_54926601 | 3.51 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
| chr19_-_51472031 | 3.42 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr2_+_234104079 | 3.38 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr2_-_216878305 | 3.27 |
ENST00000263268.6
|
MREG
|
melanoregulin |
| chr12_+_27485785 | 3.12 |
ENST00000544915.1
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
| chr22_+_31488433 | 3.11 |
ENST00000455608.1
|
SMTN
|
smoothelin |
| chr12_+_27485823 | 3.07 |
ENST00000395901.2
ENST00000546179.1 |
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
| chr9_+_140119618 | 3.06 |
ENST00000359069.2
|
C9orf169
|
chromosome 9 open reading frame 169 |
| chr15_+_45722727 | 3.03 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
| chr17_+_7942424 | 2.98 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr8_+_86376081 | 2.92 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr1_-_153433120 | 2.88 |
ENST00000368723.3
|
S100A7
|
S100 calcium binding protein A7 |
| chr2_-_31440377 | 2.87 |
ENST00000444918.2
ENST00000403897.3 |
CAPN14
|
calpain 14 |
| chr3_-_50336278 | 2.82 |
ENST00000359051.3
ENST00000417393.1 ENST00000442620.1 ENST00000452674.1 |
HYAL3
NAT6
|
hyaluronoglucosaminidase 3 N-acetyltransferase 6 (GCN5-related) |
| chr7_+_76054224 | 2.78 |
ENST00000394857.3
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor) |
| chr21_+_30502806 | 2.75 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr1_+_154975258 | 2.71 |
ENST00000417934.2
|
ZBTB7B
|
zinc finger and BTB domain containing 7B |
| chr19_-_19049791 | 2.68 |
ENST00000594439.1
ENST00000221222.11 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr14_-_24732368 | 2.67 |
ENST00000544573.1
|
TGM1
|
transglutaminase 1 |
| chr2_-_72375167 | 2.64 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
| chr8_+_27182862 | 2.62 |
ENST00000521164.1
ENST00000346049.5 |
PTK2B
|
protein tyrosine kinase 2 beta |
| chr2_+_113885138 | 2.62 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
| chr19_-_40324767 | 2.61 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr8_+_144816303 | 2.61 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
| chr17_-_41623691 | 2.61 |
ENST00000545954.1
|
ETV4
|
ets variant 4 |
| chr19_-_43032532 | 2.58 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| chr17_-_41623075 | 2.54 |
ENST00000545089.1
|
ETV4
|
ets variant 4 |
| chr7_+_116166331 | 2.54 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr7_+_100770328 | 2.52 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
| chr19_+_6464502 | 2.51 |
ENST00000308243.7
|
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr14_-_24732403 | 2.50 |
ENST00000206765.6
|
TGM1
|
transglutaminase 1 |
| chr8_+_27183033 | 2.50 |
ENST00000420218.2
|
PTK2B
|
protein tyrosine kinase 2 beta |
| chr1_-_186649543 | 2.46 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
| chr1_+_32042131 | 2.46 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr19_+_42301079 | 2.43 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
| chr1_+_32042105 | 2.43 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr6_+_151646800 | 2.42 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr14_+_75746340 | 2.41 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr14_+_75746781 | 2.40 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr9_+_33795533 | 2.40 |
ENST00000379405.3
|
PRSS3
|
protease, serine, 3 |
| chr5_+_148521381 | 2.40 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr11_+_33061543 | 2.29 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
| chr17_+_74372662 | 2.28 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
| chr19_+_39279838 | 2.19 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
| chr5_+_148521046 | 2.18 |
ENST00000326685.7
ENST00000356541.3 ENST00000309868.7 |
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr19_+_45281118 | 2.15 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr5_-_139726181 | 2.13 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
| chr22_+_45148432 | 2.13 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
| chr17_-_39942940 | 2.12 |
ENST00000310706.5
ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP
|
junction plakoglobin |
| chr1_+_3370990 | 2.11 |
ENST00000378378.4
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
| chr9_+_34990219 | 2.10 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
| chr19_+_6531010 | 2.09 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
| chrX_-_153602991 | 2.08 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
| chr19_-_36001113 | 2.08 |
ENST00000434389.1
|
DMKN
|
dermokine |
| chr19_+_35645817 | 2.06 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr5_+_148521136 | 2.06 |
ENST00000506113.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr8_-_6735451 | 2.06 |
ENST00000297439.3
|
DEFB1
|
defensin, beta 1 |
| chr7_+_2687173 | 2.06 |
ENST00000403167.1
|
TTYH3
|
tweety family member 3 |
| chr12_-_57634475 | 2.05 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr6_-_10419871 | 2.02 |
ENST00000319516.4
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr1_+_152957707 | 2.02 |
ENST00000368762.1
|
SPRR1A
|
small proline-rich protein 1A |
| chr1_-_204116078 | 2.02 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
| chr17_-_41623259 | 2.01 |
ENST00000538265.1
ENST00000591713.1 |
ETV4
|
ets variant 4 |
| chr19_+_42212501 | 2.01 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
| chr7_+_44663908 | 1.99 |
ENST00000543843.1
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
| chr2_-_165477971 | 1.99 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr11_-_2158507 | 1.98 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr3_-_48594248 | 1.97 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
| chr8_+_95653427 | 1.97 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chrX_-_107018969 | 1.95 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr10_+_11060004 | 1.94 |
ENST00000542579.1
ENST00000399850.3 ENST00000417956.2 |
CELF2
|
CUGBP, Elav-like family member 2 |
| chr5_-_149669192 | 1.92 |
ENST00000398376.3
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr18_-_28682374 | 1.92 |
ENST00000280904.6
|
DSC2
|
desmocollin 2 |
| chr7_+_43622664 | 1.92 |
ENST00000319357.5
|
STK17A
|
serine/threonine kinase 17a |
| chr22_+_19467261 | 1.90 |
ENST00000455750.1
ENST00000437685.2 ENST00000263201.1 ENST00000404724.3 |
CDC45
|
cell division cycle 45 |
| chr19_+_42212526 | 1.89 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
| chr12_+_53491220 | 1.87 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chrX_-_48328551 | 1.85 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr11_+_69061594 | 1.84 |
ENST00000441339.2
ENST00000308946.3 ENST00000535407.1 |
MYEOV
|
myeloma overexpressed |
| chr17_+_17942684 | 1.84 |
ENST00000376345.3
|
GID4
|
GID complex subunit 4 |
| chr18_-_28681950 | 1.84 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
| chr19_+_6464243 | 1.83 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
| chrX_-_152939252 | 1.82 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr15_+_63340858 | 1.80 |
ENST00000560615.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr6_+_41604747 | 1.79 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
| chrX_-_48328631 | 1.79 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr1_-_27286897 | 1.79 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
| chr19_-_51456198 | 1.77 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr17_+_73717407 | 1.77 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
| chr19_-_43269809 | 1.75 |
ENST00000406636.3
ENST00000404209.4 ENST00000306511.4 |
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
| chr7_-_97501411 | 1.75 |
ENST00000437628.1
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr7_-_97501432 | 1.75 |
ENST00000394309.3
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr8_-_125577940 | 1.74 |
ENST00000519168.1
ENST00000395508.2 |
MTSS1
|
metastasis suppressor 1 |
| chr8_+_95653302 | 1.70 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chrX_+_131157609 | 1.69 |
ENST00000496850.1
|
MST4
|
Serine/threonine-protein kinase MST4 |
| chr15_-_34610962 | 1.68 |
ENST00000290209.5
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
| chr7_-_752577 | 1.68 |
ENST00000544935.1
ENST00000430040.1 ENST00000456696.2 ENST00000406797.1 |
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
| chr14_-_80677815 | 1.68 |
ENST00000557125.1
ENST00000555750.1 |
DIO2
|
deiodinase, iodothyronine, type II |
| chr17_-_41623716 | 1.68 |
ENST00000319349.5
|
ETV4
|
ets variant 4 |
| chr17_-_38657849 | 1.67 |
ENST00000254051.6
|
TNS4
|
tensin 4 |
| chr15_+_63340734 | 1.66 |
ENST00000560959.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr10_+_50822480 | 1.64 |
ENST00000455728.2
|
CHAT
|
choline O-acetyltransferase |
| chr1_-_153363452 | 1.63 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
| chr4_+_156680518 | 1.62 |
ENST00000513437.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr17_-_26903900 | 1.62 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
| chr19_+_45843994 | 1.62 |
ENST00000391946.2
|
KLC3
|
kinesin light chain 3 |
| chr17_+_37894179 | 1.61 |
ENST00000577695.1
ENST00000309156.4 ENST00000309185.3 |
GRB7
|
growth factor receptor-bound protein 7 |
| chr11_+_69924397 | 1.61 |
ENST00000355303.5
|
ANO1
|
anoctamin 1, calcium activated chloride channel |
| chr22_+_40390930 | 1.61 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
| chr15_+_90728145 | 1.59 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr17_+_73717551 | 1.59 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
| chr15_+_63340775 | 1.59 |
ENST00000559281.1
ENST00000317516.7 |
TPM1
|
tropomyosin 1 (alpha) |
| chr9_-_123638633 | 1.59 |
ENST00000456291.1
|
PHF19
|
PHD finger protein 19 |
| chrX_-_152939133 | 1.58 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr15_+_63340553 | 1.58 |
ENST00000334895.5
|
TPM1
|
tropomyosin 1 (alpha) |
| chr18_+_34124507 | 1.58 |
ENST00000591635.1
|
FHOD3
|
formin homology 2 domain containing 3 |
| chr7_+_143013198 | 1.56 |
ENST00000343257.2
|
CLCN1
|
chloride channel, voltage-sensitive 1 |
| chr8_+_38065104 | 1.55 |
ENST00000521311.1
|
BAG4
|
BCL2-associated athanogene 4 |
| chr8_-_101661887 | 1.54 |
ENST00000311812.2
|
SNX31
|
sorting nexin 31 |
| chr14_+_85996471 | 1.54 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr2_-_31637560 | 1.54 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr8_+_95653373 | 1.54 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr1_-_205419053 | 1.53 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
| chr7_-_44229022 | 1.52 |
ENST00000403799.3
|
GCK
|
glucokinase (hexokinase 4) |
| chr5_+_68463043 | 1.52 |
ENST00000508407.1
ENST00000505500.1 |
CCNB1
|
cyclin B1 |
| chrX_-_15683147 | 1.52 |
ENST00000380342.3
|
TMEM27
|
transmembrane protein 27 |
| chr15_+_63340647 | 1.51 |
ENST00000404484.4
|
TPM1
|
tropomyosin 1 (alpha) |
| chr22_-_32555275 | 1.50 |
ENST00000382097.3
|
C22orf42
|
chromosome 22 open reading frame 42 |
| chr2_+_33172012 | 1.50 |
ENST00000404816.2
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr9_-_131940526 | 1.49 |
ENST00000372491.2
|
IER5L
|
immediate early response 5-like |
| chr3_+_57882024 | 1.48 |
ENST00000494088.1
|
SLMAP
|
sarcolemma associated protein |
| chr18_+_47088401 | 1.47 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr21_-_38639601 | 1.47 |
ENST00000539844.1
ENST00000476950.1 ENST00000399001.1 |
DSCR3
|
Down syndrome critical region gene 3 |
| chr6_-_131277510 | 1.47 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr19_-_11689752 | 1.47 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr19_-_36001286 | 1.46 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr17_-_8113886 | 1.46 |
ENST00000577833.1
ENST00000534871.1 ENST00000583915.1 ENST00000316199.6 ENST00000581511.1 ENST00000585124.1 |
AURKB
|
aurora kinase B |
| chr14_-_53162361 | 1.46 |
ENST00000395686.3
|
ERO1L
|
ERO1-like (S. cerevisiae) |
| chr7_+_116165754 | 1.46 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr17_+_37894570 | 1.46 |
ENST00000394211.3
|
GRB7
|
growth factor receptor-bound protein 7 |
| chr5_-_178017355 | 1.45 |
ENST00000390654.3
|
COL23A1
|
collagen, type XXIII, alpha 1 |
| chrX_-_153775426 | 1.44 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr1_+_154975110 | 1.44 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
| chr8_-_91095099 | 1.43 |
ENST00000265431.3
|
CALB1
|
calbindin 1, 28kDa |
| chr5_+_68462944 | 1.43 |
ENST00000506572.1
|
CCNB1
|
cyclin B1 |
| chr16_-_4987065 | 1.42 |
ENST00000590782.2
ENST00000345988.2 |
PPL
|
periplakin |
| chr9_+_35673853 | 1.42 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
| chrX_-_109561294 | 1.42 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
| chr17_-_39553844 | 1.42 |
ENST00000251645.2
|
KRT31
|
keratin 31 |
| chr12_-_91505608 | 1.42 |
ENST00000266718.4
|
LUM
|
lumican |
| chr2_+_17721230 | 1.42 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
| chr7_-_97501733 | 1.42 |
ENST00000444334.1
ENST00000422745.1 ENST00000394308.3 ENST00000451771.1 ENST00000175506.4 |
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr1_+_16085244 | 1.41 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
| chr21_-_45079341 | 1.40 |
ENST00000443485.1
ENST00000291560.2 |
HSF2BP
|
heat shock transcription factor 2 binding protein |
| chr9_-_99064386 | 1.40 |
ENST00000375262.2
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
| chr17_-_74497432 | 1.40 |
ENST00000590288.1
ENST00000313080.4 ENST00000592123.1 ENST00000591255.1 ENST00000585989.1 ENST00000591697.1 ENST00000389760.4 |
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila) |
| chr7_+_142457315 | 1.39 |
ENST00000486171.1
ENST00000311737.7 |
PRSS1
|
protease, serine, 1 (trypsin 1) |
| chr1_-_159915386 | 1.38 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
| chr11_+_60699222 | 1.37 |
ENST00000536409.1
|
TMEM132A
|
transmembrane protein 132A |
| chr1_+_192127578 | 1.36 |
ENST00000367460.3
|
RGS18
|
regulator of G-protein signaling 18 |
| chr17_-_7165662 | 1.36 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr18_+_29077990 | 1.36 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr8_-_127570603 | 1.36 |
ENST00000304916.3
|
FAM84B
|
family with sequence similarity 84, member B |
| chr7_-_107642348 | 1.36 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr8_+_102504651 | 1.35 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chrX_+_69509927 | 1.35 |
ENST00000374403.3
|
KIF4A
|
kinesin family member 4A |
| chr3_+_186915274 | 1.35 |
ENST00000312295.4
|
RTP1
|
receptor (chemosensory) transporter protein 1 |
| chr4_-_47983519 | 1.35 |
ENST00000358519.4
ENST00000544810.1 ENST00000402813.3 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
| chr6_+_41606176 | 1.34 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
| chr12_-_48298785 | 1.34 |
ENST00000550325.1
ENST00000546653.1 ENST00000549336.1 ENST00000535672.1 ENST00000229022.3 ENST00000548664.1 |
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor |
| chr11_+_94822968 | 1.34 |
ENST00000278505.4
|
ENDOD1
|
endonuclease domain containing 1 |
| chr2_-_224702257 | 1.34 |
ENST00000409375.1
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit |
| chr7_-_97501706 | 1.34 |
ENST00000455086.1
ENST00000453600.1 |
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr12_+_110011571 | 1.34 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
| chr4_+_54966198 | 1.33 |
ENST00000326902.2
ENST00000503800.1 |
GSX2
|
GS homeobox 2 |
| chr14_+_68086515 | 1.32 |
ENST00000261783.3
|
ARG2
|
arginase 2 |
| chr1_-_43855444 | 1.32 |
ENST00000372455.4
|
MED8
|
mediator complex subunit 8 |
| chr2_-_235405168 | 1.32 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr2_+_11817713 | 1.31 |
ENST00000449576.2
|
LPIN1
|
lipin 1 |
| chr19_-_40324255 | 1.31 |
ENST00000593685.1
ENST00000600611.1 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr19_+_8429031 | 1.31 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
| chr15_+_75639773 | 1.31 |
ENST00000567657.1
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli) |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZEB1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.6 | 6.3 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 1.5 | 6.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.4 | 4.2 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 1.3 | 4.0 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.3 | 4.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 1.3 | 7.8 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.2 | 26.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.1 | 3.4 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.1 | 3.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.1 | 8.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 1.0 | 4.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.0 | 8.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.0 | 9.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.0 | 7.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.0 | 2.9 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.0 | 2.9 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.9 | 7.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.9 | 2.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.9 | 0.9 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.9 | 4.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.9 | 2.6 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) insulin catabolic process(GO:1901143) |
| 0.8 | 1.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.8 | 2.5 | GO:2000097 | chronological cell aging(GO:0001300) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.8 | 2.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.8 | 2.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.7 | 3.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.7 | 2.1 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.7 | 2.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.6 | 2.5 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.6 | 1.9 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.6 | 1.9 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.6 | 1.9 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.6 | 3.6 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.6 | 1.2 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.6 | 2.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.6 | 0.6 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.6 | 5.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 | 1.8 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.6 | 3.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.6 | 2.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.6 | 4.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.6 | 7.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.6 | 2.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.5 | 2.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.5 | 0.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.5 | 1.6 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.5 | 1.6 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 | 2.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.5 | 2.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.5 | 2.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 | 2.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.5 | 2.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 | 3.4 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.5 | 1.9 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 | 7.2 | GO:0035878 | nail development(GO:0035878) |
| 0.5 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 0.9 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.5 | 0.9 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.5 | 1.4 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.5 | 1.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.4 | 1.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 | 5.2 | GO:1905031 | regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
| 0.4 | 3.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.4 | 3.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 1.3 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.4 | 1.6 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.4 | 3.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.4 | 1.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.4 | 2.0 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.4 | 1.2 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.4 | 4.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 2.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.4 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.4 | 1.2 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.4 | 3.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 2.7 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 1.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 | 0.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.4 | 1.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.4 | 1.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.4 | 1.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.4 | 1.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 2.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.4 | 1.1 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.4 | 2.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.4 | 3.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.4 | 1.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 2.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 | 2.1 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.3 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.3 | 2.4 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.3 | 1.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 | 6.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.3 | 1.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 | 1.3 | GO:0007343 | egg activation(GO:0007343) |
| 0.3 | 0.7 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.3 | 2.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.3 | 1.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 2.3 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.3 | 0.3 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.3 | 2.6 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.3 | 0.6 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.3 | 1.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 | 1.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.3 | 2.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.3 | 0.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.3 | 1.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.3 | 2.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.3 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 1.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 7.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.3 | 0.9 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.3 | 4.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 0.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.3 | 1.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 | 6.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.3 | 4.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 2.0 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 0.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.3 | 1.2 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.3 | 1.5 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.3 | 1.2 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.3 | 0.9 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.3 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 2.9 | GO:0072025 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.3 | 1.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 | 2.2 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.3 | 9.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.3 | 0.8 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
| 0.3 | 2.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 | 0.8 | GO:0048627 | myoblast development(GO:0048627) |
| 0.3 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 | 3.7 | GO:0015816 | glycine transport(GO:0015816) |
| 0.3 | 1.8 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.3 | 0.5 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 | 1.0 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 | 1.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 2.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 | 3.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.3 | 0.8 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 | 1.0 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 0.2 | 0.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.2 | 1.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.2 | 4.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.2 | 1.7 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 | 1.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.2 | 1.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 | 0.5 | GO:0071281 | cellular response to iron ion(GO:0071281) |
| 0.2 | 0.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.2 | 1.2 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.2 | 0.5 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.2 | 1.4 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.2 | 5.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.7 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 | 0.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 | 0.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.2 | 1.1 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.2 | 0.2 | GO:0002652 | regulation of tolerance induction dependent upon immune response(GO:0002652) |
| 0.2 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 0.2 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
| 0.2 | 0.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.2 | 2.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 | 0.2 | GO:0070671 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.2 | 6.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.2 | 0.6 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.2 | 1.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 0.6 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.2 | 0.6 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.2 | 1.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 | 0.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.2 | 0.6 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.2 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.2 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.2 | 1.7 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 0.8 | GO:1990164 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) histone H2A phosphorylation(GO:1990164) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.2 | 0.6 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.2 | 2.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 1.6 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 | 4.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.2 | 0.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.2 | 0.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.2 | 0.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.2 | 1.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 | 1.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.2 | 2.8 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 0.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 1.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.2 | 0.9 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.2 | 1.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.2 | 2.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 1.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 | 0.3 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.2 | 0.5 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.2 | 4.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.2 | 1.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 1.0 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.2 | 2.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.2 | 0.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 | 0.7 | GO:0030220 | platelet formation(GO:0030220) |
| 0.2 | 2.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 | 1.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 0.5 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.2 | 0.5 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.2 | 1.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 | 0.8 | GO:0099515 | nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.2 | 3.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.2 | 0.5 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.2 | 3.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 0.6 | GO:0032632 | response to molecule of fungal origin(GO:0002238) interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of gamma-delta T cell differentiation(GO:0045588) cellular response to molecule of fungal origin(GO:0071226) |
| 0.2 | 0.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 0.6 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 0.8 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 | 1.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 | 0.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.2 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.2 | 0.2 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.2 | 1.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.2 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.2 | 0.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.2 | 0.3 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.2 | 0.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.2 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 4.9 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.2 | 1.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 1.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.1 | 0.3 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) |
| 0.1 | 0.6 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 3.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.4 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 | 0.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 1.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 0.1 | 0.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.4 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 0.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 2.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.1 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.1 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 0.6 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 6.7 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 2.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.6 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.1 | 6.7 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.1 | 0.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.1 | 0.7 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.1 | 1.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 0.5 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 2.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 1.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.1 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
| 0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.1 | 0.1 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.1 | 0.3 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
| 0.1 | 0.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 1.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 2.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 | 7.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 1.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.1 | 0.4 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.1 | 1.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.1 | 0.6 | GO:0009880 | embryonic pattern specification(GO:0009880) |
| 0.1 | 0.6 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.1 | 1.6 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 0.2 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 | 0.8 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.1 | 0.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.4 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.5 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 0.1 | GO:0001768 | establishment of T cell polarity(GO:0001768) |
| 0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 0.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 4.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.1 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.2 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.1 | 1.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 0.8 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.9 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 5.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.3 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 1.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.4 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 1.9 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 | 0.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.1 | 0.3 | GO:0043049 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.1 | 1.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.1 | 0.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 | 0.4 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.1 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
| 0.1 | 1.5 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 1.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.1 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 1.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 3.4 | GO:0032402 | melanosome transport(GO:0032402) |
| 0.1 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 0.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.2 | GO:1900006 | positive regulation of dendritic spine development(GO:0060999) positive regulation of dendrite development(GO:1900006) |
| 0.1 | 0.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.6 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.1 | 0.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.5 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 | 0.7 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 2.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.1 | 3.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 1.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 2.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 3.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.1 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 1.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
| 0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 0.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 0.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 0.2 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 | 0.7 | GO:0006006 | glucose metabolic process(GO:0006006) |
| 0.1 | 1.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 0.4 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 0.5 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 0.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.3 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 | 0.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 2.4 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 | 4.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.1 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.1 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.2 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.1 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.2 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 0.3 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.1 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 0.8 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 0.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.1 | 0.6 | GO:0014870 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 | 1.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 0.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 1.3 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.2 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.1 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.1 | 0.5 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.1 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.3 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.1 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.8 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.1 | 1.0 | GO:0070646 | protein deubiquitination(GO:0016579) protein modification by small protein removal(GO:0070646) |
| 0.1 | 0.3 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.3 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 0.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.1 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 | 0.3 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 | 0.1 | GO:0072003 | kidney rudiment formation(GO:0072003) |
| 0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 1.5 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 7.6 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 0.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.1 | 1.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 0.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 2.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 1.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 1.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 2.3 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 0.4 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 0.1 | GO:0051088 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 | 1.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.1 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 | 0.2 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.1 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.1 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 5.4 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 1.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.3 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
| 0.1 | 1.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 1.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.3 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.1 | GO:0061138 | morphogenesis of a branching epithelium(GO:0061138) |
| 0.1 | 0.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.4 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.3 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 8.5 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
| 0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 0.1 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
| 0.1 | 0.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.1 | 0.4 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.1 | 1.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 1.3 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.1 | 0.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.2 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.1 | 0.3 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.1 | 0.1 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 | 0.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.1 | 0.2 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 | 1.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.2 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.1 | 1.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.1 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.1 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.8 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.1 | 1.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 0.2 | GO:1903061 | positive regulation of lipoprotein metabolic process(GO:0050747) establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) positive regulation of protein lipidation(GO:1903061) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 | 0.8 | GO:0097369 | sodium ion import(GO:0097369) |
| 0.1 | 0.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.1 | 0.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 0.8 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 1.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 0.4 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 0.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.1 | GO:0007623 | circadian rhythm(GO:0007623) |
| 0.0 | 0.6 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.0 | 0.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.0 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 | 2.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.0 | 1.5 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.0 | 1.7 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.0 | 0.4 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 | 0.6 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.0 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.0 | 0.6 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.0 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 1.5 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.0 | 0.8 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
| 0.0 | 0.8 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
| 0.0 | 1.0 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 | 0.1 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.0 | 0.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.0 | 2.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 1.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.1 | GO:0009451 | RNA modification(GO:0009451) base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 | 1.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 1.0 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.0 | 0.8 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.1 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 | 0.9 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
| 0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 | 0.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.0 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.0 | 0.2 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
| 0.0 | 0.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 0.6 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 | 0.8 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 1.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 | 0.1 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 0.1 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.0 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.0 | 0.2 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.0 | 0.1 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.0 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.1 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.0 | 0.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 | 0.4 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.0 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.9 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 0.1 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 0.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.0 | 0.2 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.1 | GO:0035787 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) negative regulation of phospholipid biosynthetic process(GO:0071072) response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.0 | 5.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 0.1 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.1 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
| 0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.0 | 0.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.0 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
| 0.0 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 | 0.1 | GO:0032431 | positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 0.0 | 0.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.0 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.0 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.0 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.0 | 0.2 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.0 | 0.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.0 | 0.9 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.0 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
| 0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
| 0.0 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.1 | GO:0030860 | neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 | 0.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
| 0.0 | 0.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 1.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 1.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 | 1.2 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 | 0.1 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
| 0.0 | 0.1 | GO:0051781 | positive regulation of cell division(GO:0051781) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 2.0 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.0 | 0.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 | 0.4 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.0 | 0.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 0.2 | GO:2000106 | lymphocyte apoptotic process(GO:0070227) regulation of lymphocyte apoptotic process(GO:0070228) regulation of leukocyte apoptotic process(GO:2000106) |
| 0.0 | 0.2 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.0 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
| 0.0 | 1.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
| 0.0 | 0.4 | GO:0048667 | cell morphogenesis involved in neuron differentiation(GO:0048667) |
| 0.0 | 0.4 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 | 0.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.1 | GO:0031098 | stress-activated protein kinase signaling cascade(GO:0031098) |
| 0.0 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 | 0.2 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.0 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.6 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.2 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.0 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 0.2 | GO:0048753 | pigment granule organization(GO:0048753) |
| 0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.6 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
| 0.0 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.0 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.0 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.0 | 0.3 | GO:0051828 | entry into host cell(GO:0030260) entry into host(GO:0044409) viral entry into host cell(GO:0046718) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 | 0.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 0.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 | 0.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 | 0.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.0 | 0.1 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.0 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
| 0.0 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.0 | 0.1 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
| 0.0 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
| 0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.0 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.0 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.0 | 0.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 0.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) negative regulation of oocyte development(GO:0060283) regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 1.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.0 | 0.2 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.0 | 0.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.3 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 1.1 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 | 0.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 1.1 | 8.6 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.0 | 2.9 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.8 | 4.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.8 | 7.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.8 | 4.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.7 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.6 | 11.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.5 | 1.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.5 | 0.5 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.5 | 2.1 | GO:1990742 | microvesicle(GO:1990742) |
| 0.5 | 3.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.5 | 2.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.5 | 3.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 1.7 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.4 | 1.3 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.4 | 1.2 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.4 | 24.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.4 | 1.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.3 | 8.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.3 | 0.3 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.3 | 1.3 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.3 | 2.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.3 | 3.5 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 4.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.3 | 1.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.3 | 4.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.3 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.3 | 1.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.3 | 4.7 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.3 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.3 | 5.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.2 | 0.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.2 | 1.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.2 | 0.7 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 1.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 3.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 4.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 0.6 | GO:0030849 | Y chromosome(GO:0000806) autosome(GO:0030849) |
| 0.2 | 1.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.2 | 0.6 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.2 | 2.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.2 | 0.6 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.2 | 2.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.2 | 5.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 2.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.2 | 3.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 0.7 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.2 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
| 0.2 | 1.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 0.5 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.2 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.2 | 1.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 5.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 1.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 0.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.4 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 3.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 12.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 2.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 5.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.1 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.1 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.1 | 0.4 | GO:0044753 | amphisome(GO:0044753) |
| 0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 1.3 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 1.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 1.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.6 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.1 | 1.9 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 2.8 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 0.1 | GO:0099568 | cytoplasmic region(GO:0099568) |
| 0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 0.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 2.2 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.1 | 2.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 1.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 1.1 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 1.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.1 | 0.5 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 9.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 1.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 2.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.1 | 1.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 2.1 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.1 | 8.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 6.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 0.7 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
| 0.1 | 0.7 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 2.0 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 5.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 7.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 0.2 | GO:0099634 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.3 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.3 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.1 | 0.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 2.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 0.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 3.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.2 | GO:0044449 | contractile fiber part(GO:0044449) |
| 0.0 | 0.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 2.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 1.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 2.4 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.0 | 3.1 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 4.9 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.4 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 1.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 2.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 6.3 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.0 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.0 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.0 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 1.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.0 | 0.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.6 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 2.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.0 | 2.0 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 1.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 3.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 1.7 | GO:0000791 | euchromatin(GO:0000791) |
| 0.0 | 6.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.0 | 4.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 7.5 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 1.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
| 0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
| 0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 43.7 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 2.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.0 | 4.1 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 1.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) symmetric synapse(GO:0032280) |
| 0.0 | 0.1 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 1.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
| 0.0 | 0.4 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 10.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 4.1 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
| 0.0 | 1.0 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.0 | 0.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.0 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.2 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
| 0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.3 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 1.1 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 1.0 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 2.2 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 2.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 0.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.1 | GO:0032590 | neuron projection membrane(GO:0032589) dendrite membrane(GO:0032590) |
| 0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.2 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.7 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 0.0 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 1.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 1.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 7.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 1.7 | 5.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.3 | 4.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.3 | 6.3 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 1.2 | 1.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 1.1 | 6.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 1.1 | 5.4 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 1.0 | 9.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.9 | 2.8 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.7 | 3.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.7 | 2.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.7 | 6.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.6 | 3.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.6 | 2.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.6 | 4.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.6 | 1.8 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.6 | 3.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.6 | 2.8 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.6 | 3.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.6 | 0.6 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.5 | 2.7 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.5 | 5.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.5 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.5 | 5.2 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.5 | 2.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.5 | 2.0 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.5 | 1.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.5 | 1.9 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.5 | 1.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.5 | 4.2 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 1.4 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.5 | 4.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.4 | 1.7 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.4 | 2.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.4 | 6.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.4 | 5.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.4 | 1.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.4 | 2.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.4 | 1.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.4 | 1.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 1.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.4 | 1.6 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.4 | 2.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.4 | 4.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.4 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.4 | 2.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.4 | 1.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.4 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 2.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 2.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
| 0.3 | 3.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 1.0 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.3 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 3.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.3 | 5.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.3 | 1.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.3 | 1.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.3 | 3.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.3 | 4.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.3 | 0.9 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 1.2 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 0.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.3 | 1.5 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.3 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.3 | 2.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 2.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.3 | 3.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.3 | 1.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 3.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.3 | 1.6 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.3 | 2.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.3 | 1.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.3 | 1.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.3 | 1.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.3 | 2.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 1.0 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.3 | 1.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.3 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.3 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.3 | 2.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 0.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.3 | 1.3 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 1.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 2.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 0.7 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.2 | 5.8 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 0.7 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.2 | 1.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 0.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 0.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.2 | 2.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.2 | 0.7 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.2 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 4.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 1.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.2 | 0.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.2 | 2.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 0.8 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.2 | 1.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 3.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.2 | 1.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.2 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 1.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.2 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.2 | 0.6 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.2 | 0.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.2 | 1.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.2 | 1.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.2 | 3.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 5.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 0.7 | GO:0048037 | cofactor binding(GO:0048037) |
| 0.2 | 2.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 3.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.2 | 0.5 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 0.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.2 | 0.5 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 1.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.2 | 3.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 1.3 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 3.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 0.8 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.2 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 0.5 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.2 | 0.5 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.2 | 0.5 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.2 | 0.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.2 | 1.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.2 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.2 | 0.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 0.5 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.2 | 2.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 4.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.9 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 0.6 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 6.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 1.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.1 | 8.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 7.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 2.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.1 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 4.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 3.6 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 1.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 0.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 14.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.4 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.1 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 2.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.1 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 38.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.4 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.1 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.1 | 0.4 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.3 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.1 | 0.3 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.1 | 4.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.1 | 2.1 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.1 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 0.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 1.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.1 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 1.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.3 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 1.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 1.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.6 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
| 0.1 | 3.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.1 | 2.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 5.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.6 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 3.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.1 | 2.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 1.7 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.2 | GO:0016836 | carbon-oxygen lyase activity(GO:0016835) hydro-lyase activity(GO:0016836) |
| 0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 2.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.1 | 0.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 0.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.1 | 1.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 1.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 7.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.3 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 3.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 13.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.1 | 2.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 1.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 1.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 1.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 2.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.1 | 1.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 0.4 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 2.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.1 | 0.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 0.4 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 1.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.1 | 3.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 1.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.1 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.2 | GO:0047325 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.1 | 0.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 4.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 0.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.1 | 2.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.0 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.0 | 0.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 2.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 2.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.0 | 0.1 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.0 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
| 0.0 | 1.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.0 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.0 | 0.1 | GO:0070405 | ammonium ion binding(GO:0070405) |
| 0.0 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.0 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 18.4 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 1.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.2 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 3.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 1.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.9 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.0 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.0 | 0.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.1 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.0 | 2.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 6.7 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.0 | 0.2 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.0 | 0.2 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 1.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 3.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.1 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.0 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.0 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.0 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.0 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.0 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.0 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.0 | 1.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 0.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 1.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.0 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 11.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.1 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.0 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.0 | 0.2 | GO:0004518 | nuclease activity(GO:0004518) |
| 0.0 | 0.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.0 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.2 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.8 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.0 | 0.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.0 | 4.6 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 2.3 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 1.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.0 | 0.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.0 | 0.1 | GO:0070696 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 0.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 0.4 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.0 | 0.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 13.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 8.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.5 | 33.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 5.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 9.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 4.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 5.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 5.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 8.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.2 | 11.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 6.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 16.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 5.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 3.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 8.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 5.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 1.3 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 3.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 3.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 4.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 3.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 3.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 4.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 4.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 1.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 4.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 21.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 2.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 2.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 1.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 2.6 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 2.0 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 2.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 3.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.0 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 2.0 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 1.3 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 2.9 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 7.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 1.2 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 3.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 1.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 10.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.4 | 8.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.3 | 10.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.3 | 4.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.3 | 3.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 4.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 8.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 5.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 4.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.2 | 14.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 7.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 7.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 11.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 4.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 6.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 4.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 2.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.2 | 5.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 6.1 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 14.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.2 | 3.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 3.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 2.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 1.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 2.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 1.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 3.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 2.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 3.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 1.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 5.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 1.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 5.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 2.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 6.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 1.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 2.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 1.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 1.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 1.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 2.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.1 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 4.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 0.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 1.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 2.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 4.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 2.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 1.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 2.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 2.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 2.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 0.3 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
| 0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 3.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 3.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 2.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 2.3 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 3.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 1.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 2.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.0 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 2.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.0 | 1.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 1.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 2.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 3.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.0 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 1.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.0 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.0 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.5 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 1.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 1.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.0 | 1.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 0.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 1.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 2.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 0.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 1.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.0 | 0.2 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |